In people with confirmed Alzheimer’s dementia, the β1-42 peptide is reduced in the cerebrospinal fluid, while total tau (t-tau) and phosphorylated tau (pTau) proteins are elevated6. This evidence concerns the gene MAPT and Alzheimer disease.